| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 30, 2024 | TMO Thermo Fisher Scientific Inc. | Casper Marc N59 | Chairman &CEO | Sell | 16,300 | $606.12 | $9,879,803.99 | -0.6% | -10.2% | -22.4% | |
| Jul 29, 2024 | NTRA Natera, Inc. | Moshkevich Solomon | President, Clinicaldiagnostics | Sell | 1,196 | $102.77 | $122,907.78 | -1.1% | +16.3% | +30.9% | |
| Jul 29, 2024 | WGS Genedx Holdings Corp. | Feeley Kevin46 | Chief Financial Officer | Sell | 274 | $33.54 | $9,189.96 | -0.7% | +66.4% | +172.4% | |
| Jul 29, 2024 | WGS Genedx Holdings Corp. | Opko Health, Inc. | 10% Owner | Sell | 50,000 | $33.86 | $1,692,890.00 | -1.6% | +66.4% | +172.4% | |
| Jul 29, 2024 | WGS Genedx Holdings Corp. | Stueland Katherine | Chief Executive Officer | Sell | 2,154 | $33.54 | $72,245.16 | -2.3% | +66.4% | +172.4% | |
| Jul 29, 2024 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 4,084 | $102.77 | $419,695.12 | -1.9% | +16.3% | +30.9% | |
| Jul 29, 2024 | NTRA Natera, Inc. | Fesko John | President, Chief Bus. Officer | Sell | 929 | $102.77 | $95,469.34 | -0.8% | +16.3% | +30.9% | |
| Jul 29, 2024 | NTRA Natera, Inc. | Rabinowitz Daniel48 | Sec. And Chief Legal Officer | Sell | 1,057 | $102.77 | $108,623.34 | -0.5% | +16.3% | +30.9% | |
| Jul 29, 2024 | CSTL Castle Biosciences Inc | Oelschlager Kristen M72 | Chief Operating Officer | Sell | 2,793 | $22.06 | $61,621.96 | -1.9% | +47.1% | -26.3% | |
| Jul 26, 2024 | TMO Thermo Fisher Scientific Inc. | Britt Lisa P.69 | Sr. VP And Chief Hr Officer | Sell | 3,624 | $613.02 | $2,221,582.08 | -11.4% | -8.2% | -21.2% | |
| Jul 26, 2024 | TMO Thermo Fisher Scientific Inc. | Holmes Joseph R. | VP &Chief Accounting Officer | Sell | 860 | $611.03 | $525,484.20 | -19.2% | -8.2% | -21.2% | |
| Jul 26, 2024 | TMO Thermo Fisher Scientific Inc. | Boxer Michael A59 | SVP And General Counsel | Sell | 2,000 | $600.85 | $1,201,700.00 | -13.3% | -8.2% | -21.2% | |
| Jul 26, 2024 | A Agilent Technologies, Inc. | McDonnell Padraig71 | President And CEO | Sell | 1,958 | $140.00 | $274,120.00 | -7.0% | -4.8% | -12.5% | |
| Jul 26, 2024 | TMO Thermo Fisher Scientific Inc. | Pettiti Gianluca63 | Executive Vice President | Sell | 300 | $600.85 | $180,255.00 | -1.6% | -8.2% | -21.2% | |
| Jul 26, 2024 | WGS Genedx Holdings Corp. | Opko Health, Inc. | 10% Owner | Sell | 135,000 | $33.78 | $4,560,363.00 | -2.1% | +76.2% | +138.1% | |
| Jul 26, 2024 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 2,359 | $104.39 | $246,263.82 | -1.0% | +16.1% | +35.3% | |
| Jul 25, 2024 | DHR Danaher Corp /de/ | Raskas Daniel67 | SVP - Corporate Development | Sell | 14,507 | $270.51 | $3,924,352.40 | -38.1% | -5.2% | -23.9% | |
| Jul 25, 2024 | DHR Danaher Corp /de/ | Ellis Brian W62 | Senior Vice President - GC | Sell | 9,600 | $275.16 | $2,641,536.00 | -32.2% | -5.2% | -23.9% | |
| Jul 23, 2024 | TWST Twist Bioscience Corp | Finn Patrick John73 | President And COO | Sell | 2,207 | $56.63 | $124,971.38 | -1.3% | -23.0% | -38.8% | |
| Jul 23, 2024 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 1,558 | $105.88 | $164,955.57 | -1.0% | +13.1% | +29.4% | |
| Jul 23, 2024 | WGS Genedx Holdings Corp. | Opko Health, Inc. | 10% Owner | Sell | 150,000 | $32.98 | $4,946,935.00 | -1.5% | +74.8% | +149.2% | |
| Jul 22, 2024 | NTRA Natera, Inc. | Fesko John | President, Chief Bus. Officer | Sell | 549 | $105.16 | $57,732.40 | -0.5% | +14.2% | +32.6% | |
| Jul 22, 2024 | NTRA Natera, Inc. | Moshkevich Solomon | President, Clinicaldiagnostics | Sell | 549 | $105.16 | $57,732.68 | -0.5% | +14.2% | +32.6% | |
| Jul 22, 2024 | NTRA Natera, Inc. | Rabinowitz Daniel48 | Sec. And Chief Legal Officer | Sell | 815 | $105.16 | $85,704.34 | -0.4% | +14.2% | +32.6% | |
| Jul 22, 2024 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 2,638 | $105.16 | $277,409.71 | -1.2% | +14.2% | +32.6% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.